Kaitlyn Hoover1, Steve Lockhart2, Catherine Callister3, Jodi Summers Holtrop4, Susan L Calcaterra5. 1. Clinical Science Graduate Program, University of Colorado, Aurora, CO, USA. Electronic address: kaitlyn.hoover@cuanschutz.edu. 2. Adult and Child Consortium for Health Outcomes Research and Delivery Service, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, USA. 3. Division of Hospital Medicine, University of Colorado, Aurora, CO, USA. 4. Department of Family Medicine, University of Colorado, Aurora, CO, USA. 5. Division of Hospital Medicine, University of Colorado, Aurora, CO, USA; Division of General Internal Medicine, University of Colorado, Aurora, CO, USA.
Abstract
BACKGROUND: Addiction consultation services (ACS) provide evidence-based treatment to hospitalized patients with substance use disorders (SUD). Expansion of hospital-based addiction care may help to counteract the stigma that patients with SUD experience within the health care system. Stigma is among the most impactful barriers to seeking care and adhering to medical advice among people with SUD. We aimed to understand how the presence of an ACS affected patients' and hospital-based providers' experiences with stigma in the hospital setting. METHODS: We conducted a qualitative study utilizing focus groups and key informant interviews with hospital-based providers (hospitalists and hospital-based nurses, social workers, pharmacists). We also conducted key informant interviews with patients who received care from an ACS during their hospitalization. An interprofessional team coded and analyzed transcripts using a thematic analysis approach to identify emergent themes. RESULTS: Sixty-two hospital-based providers participated in six focus groups or eight interviews. Twenty patients participated in interviews. Four themes emerged relating to the experiences of stigma reported by hospital-based providers and hospitalized patients with SUD: (1) past experiences in the health care system propagate a cycle of stigmatization between hospital-based providers and patients; (2) documentation in medical charts unintentionally or intentionally perpetuates enacted stigma among hospital-based providers resulting in anticipated stigma among patients; (3) the presence of an ACS reduces enacted stigma among hospital-based providers through expanding the use of evidenced-based SUD treatment and reframing the SUD narrative; (4) ACS team members combat the effects of internalized stigma by promoting feelings of self-worth, self-efficacy, and mutual respect among patients with SUD. CONCLUSIONS: An ACS can facilitate destigmatization of hospitalized patients with SUD by incorporating evidence-based SUD treatment into routine hospital care, by providing and modeling compassionate care, and by reframing addiction as a chronic condition to be treated alongside other medical conditions. Future reductions of stigma in hospital settings may result from promoting greater use of evidence-based treatment for SUD and expanded education for health care providers on the use of non-stigmatizing language and medical terminology when documenting SUD in the medical chart.
BACKGROUND: Addiction consultation services (ACS) provide evidence-based treatment to hospitalized patients with substance use disorders (SUD). Expansion of hospital-based addiction care may help to counteract the stigma that patients with SUD experience within the health care system. Stigma is among the most impactful barriers to seeking care and adhering to medical advice among people with SUD. We aimed to understand how the presence of an ACS affected patients' and hospital-based providers' experiences with stigma in the hospital setting. METHODS: We conducted a qualitative study utilizing focus groups and key informant interviews with hospital-based providers (hospitalists and hospital-based nurses, social workers, pharmacists). We also conducted key informant interviews with patients who received care from an ACS during their hospitalization. An interprofessional team coded and analyzed transcripts using a thematic analysis approach to identify emergent themes. RESULTS: Sixty-two hospital-based providers participated in six focus groups or eight interviews. Twenty patients participated in interviews. Four themes emerged relating to the experiences of stigma reported by hospital-based providers and hospitalized patients with SUD: (1) past experiences in the health care system propagate a cycle of stigmatization between hospital-based providers and patients; (2) documentation in medical charts unintentionally or intentionally perpetuates enacted stigma among hospital-based providers resulting in anticipated stigma among patients; (3) the presence of an ACS reduces enacted stigma among hospital-based providers through expanding the use of evidenced-based SUD treatment and reframing the SUD narrative; (4) ACS team members combat the effects of internalized stigma by promoting feelings of self-worth, self-efficacy, and mutual respect among patients with SUD. CONCLUSIONS: An ACS can facilitate destigmatization of hospitalized patients with SUD by incorporating evidence-based SUD treatment into routine hospital care, by providing and modeling compassionate care, and by reframing addiction as a chronic condition to be treated alongside other medical conditions. Future reductions of stigma in hospital settings may result from promoting greater use of evidence-based treatment for SUD and expanded education for health care providers on the use of non-stigmatizing language and medical terminology when documenting SUD in the medical chart.
Authors: Susan L Calcaterra; Anne D Drabkin; Sarah E Leslie; Reina Doyle; Stephen Koester; Joseph W Frank; Jennifer A Reich; Ingrid A Binswanger Journal: J Hosp Med Date: 2016-05-09 Impact factor: 2.960
Authors: Jan Gryczynski; Robert P Schwartz; Kevin E O'Grady; Lauren Restivo; Shannon G Mitchell; Jerome H Jaffe Journal: Health Aff (Millwood) Date: 2016-01 Impact factor: 6.301
Authors: Honora Englander; Konrad Dobbertin; Bonnie K Lind; Christina Nicolaidis; Peter Graven; Claire Dorfman; P Todd Korthuis Journal: J Gen Intern Med Date: 2019-12 Impact factor: 5.128
Authors: Sarah E Wakeman; Martha Kane; Elizabeth Powell; Sydney Howard; Christopher Shaw; Susan Regan Journal: J Gen Intern Med Date: 2020-06-22 Impact factor: 6.473